7 completed, 4 terminated, 3 no longer available. 5 Phase 2, 2 Not applicable, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 4, Completed 1 |
| Not applicable | 2 | Completed 2 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Jacobus Pharmaceutical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome Continuous 3,4-DAP, Taper 3,4-DAP to Placebo - Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome | Phase 2 | Completed | Jacobus Pharmaceutical | 32 | 2012-01-01 | 2017-07-11 |
| High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children 4-Aminosalicylic acid extended release granules - Crohn's Disease | Phase 2 | Terminated | Jacobus Pharmaceutical | 2 | 2007-06-01 | 2017-09-21 |
| High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease 4-Aminosalicylic acid, PASER placebo granules - Crohn's Disease | Phase 2 | Terminated | Jacobus Pharmaceutical | 54 | 2007-01-01 | 2008-10-15 |
| Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) 3-4 Diaminopyridine - Muscle Weakness | Phase 2 | Terminated | Jeffrey A. Cohen, MD | 4 | 2004-02-01 | 2019-05-21 |
| Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris Dapsone - Pemphigus Vulgaris | Phase 2 | Terminated | Jacobus Pharmaceutical | 48 | 1996-11-01 | 2007-02-05 |
| Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia Trimetrexate glucuronate, Trimethoprim, Sulfamethoxazole - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 1 | Completed | U.S. Bioscience | 20 | 2005-06-24 | |
| A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides Pentamidine isethionate, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 400 | 2021-11-01 | |
| Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine 3,4 diaminopyridine - Lambert-Eaton Myasthenic Syndrome | No longer available | David Lacomis, MD | 2019-07-09 | |||
| 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) 3,4-diaminopyridine - Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenia (CM) | No longer available | Oregon Health and Science University | 2019-12-11 | |||
| Treatment of Lambert-Eaton Syndrome With 3,4 DAP 3, 4 DAP - Lambert Eaton Myasthenic Syndrome | No longer available | David P. Richman, MD | 2019-10-30 | |||
| A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS Primaquine, Sulfamethoxazole-Trimethoprim, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 290 | 2021-11-03 | |
| A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Trimethoprim, Sulfamethoxazole, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections | Not applicable | Completed | Jacobus Pharmaceutical | 2005-06-24 | ||
| Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC) Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections | Not applicable | Completed | Jacobus Pharmaceutical | 2005-06-24 | ||
| Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 96 | 2021-11-04 |
HIV Infections (6) · Pneumonia, Pneumocystis (6) · Acquired Immunodeficiency Syndrome (5) · Lambert-Eaton Myasthenic Syndrome (4) · AIDS-Related Complex (3) · AIDS-Related Opportunistic Infections (2) · Crohn Disease (2) · Candidiasis, Oral (1) · Leukoplakia, Oral (1) · Muscle Weakness (1) · Myasthenic Syndromes, Congenital (1) · Pediatric Crohn's disease (1) · Pemphigus (1) · Primary Dysautonomias (1) · Reflex, Abnormal (1)
Dapsone (7) · Amifampridine (4) · Aminosalicylic Acid (2) · Sulfamethoxazole (2) · Trimethoprim (2) · Clindamycin (1) · Leucovorin (1) · Pentamidine (1) · Primaquine (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · trimetrexate glucuronate (1)
United States (13) · Israel (1) · Puerto Rico (1)
Amit Pandya, MD (1) · Black JR (1) · Cooper E (1) · Daniel Present, MD (1) · David P Jacobus, MD (1) · David P. Jacobus, MD (1) · David Richman, MD (1) · Diana Chen, MD (1) · El-Sadr W (1) · George D Ferry, MD (1) · Iris Dotan, MD (1) · Jeffrey A. Cohen, MD (1) · Joel R Rosh, MD (1) · John Hanson, MD (1) · Kathy L Ales, MD (1)